Genta Incorporated (GETA.OB) Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanoma 2/8/2010
More...
|
Vical Incorporated (VICL) Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma 1/28/2010
More...
|
Vical Incorporated (VICL) Announces Licensee's Approval of ONCEPT(TM) Therapeutic Melanoma Vaccine for Dogs 1/11/2010
More...
|
Pfizer Inc. (PFE) (JOBS) And Debiopharm Collaborate To Co-Develop Investigational Compound Tremelimumab (CP-675,206) In Advanced Melanoma 1/7/2010
More...
|
BioVex Announces Broadened Inclusion Criteria in Phase 3 Melanoma Study; OncoVEX to be Evaluated in First Line Patients and Those Previously Treated 1/6/2010
More...
|
Initial Phase 2 Results for Myriad Pharmaceuticals, Inc.' Azixa(TM) (MPC-6827) in Metastatic Melanoma 11/19/2009
More...
|
Abraxis BioScience, Inc. Release: ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma 11/5/2009
More...
|
BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology 11/3/2009
More...
|
Genta Incorporated (GETA.OB) Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma, Trial Fails to Meet Primary Endpoint; Stock Down 70.0% at Market Close 10/30/2009
More...
|
Studies Show Early Promise of MannKind Corporation (MNKD)'s Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid Malignancies 10/29/2009
More...
|
Myriad Pharmaceuticals, Inc.' Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R) 10/26/2009
More...
|
Melanoma Treatment Options One Step Closer, University of Alberta Study 10/21/2009
More...
|
Delcath Systems, Inc. (DCTH) Completes Phase III Study Enrollment 10/21/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 At Melanoma Conference 10/9/2009
More...
|
FDA Advisory Committee Recommends Approval of Schering-Plough Corporation (SGP)'s (JOBS) PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma 10/5/2009
More...
|
FDA Finds "Subtantial" Toxicity with Schering-Plough Corporation (SGP)'s (JOBS) PegIntron Use 10/1/2009
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial 9/25/2009
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial 9/24/2009
More...
|
Melanoma Patients Live Longer on Roche (RHHBY)'s (JOBS) Avastin 9/21/2009
More...
|
Hoag Presbyterian Memorial Hospital Release: Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy 7/29/2009
More...
|
Delcath Systems, Inc. (DCTH) Provides Update on Progress; Patient Enrollment in Phase III Metastatic Melanoma Trial Now at 79 Conference Call to Discuss Second Quarter Results Today at 4:30 PM ET 7/28/2009
More...
|
NeoGenomics, Inc. (NGNM.OB) Enters into Strategic Supply Agreement with Abbott Laboratories (ABT) (JOBS) for Development of a Melanoma Cancer Test; Abbott Has Also Acquired 9.6% of NeoGenomics Common Stock for $4.8 Million 7/24/2009
More...
|
Thallion Pharmaceuticals Inc. Halts Trial Enrollment Over Dispute 7/8/2009
More...
|
Novel Epigenetic Markers Of Melanoma May Herald New Treatments For Patients, Yale University Study 7/1/2009
More...
|
Plexxikon Inc., Roche Holding AG (RHHBF.PK)'s (JOBS) Targeted Drug Shows Promise Against Melanoma 6/1/2009
More...
|
Vaccine Trains Killer Cells to Battle Melanoma, M. D. Anderson Cancer Center Study 6/1/2009
More...
|
BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting 5/15/2009
More...
|
ZymoGenetics, Inc. (ZGEN) Reports Encouraging Preliminary Results from Phase 2 Study of IL-21 in Metastatic Melanoma Conducted by NCIC 5/13/2009
More...
|
AlphaVax, Inc. Announces Promising Results in Melanoma Studies 5/13/2009
More...
|
Vitamin D Supplements No Help Against Melanoma, Kaiser Permanente Study 5/8/2009
More...
|
Genta Incorporated (GNTA) Updates Late-Stage Progress of its Phase 3 Trial of Genasense(R) in Advanced Melanoma 4/29/2009
More...
|
BioAlliance Pharma Presents Results on Its New Biotherapy Plasmid AMEP(TM) for Metastatic Melanoma at the American Association for Cancer Research 100Th Annual Meeting in Denver, April 18 to 22, 2009 4/21/2009
More...
|
New Therapeutic Target For Melanoma Identified, Albany Medical College And Thomas Jefferson University Study 4/16/2009
More...
|
BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma 4/14/2009
More...
|
New Strategy Developed To Diagnose Melanoma, University of California, San Francisco (UCSF) Study 3/31/2009
More...
|
Data Safety Monitoring Board Unanimously Recommends Continuation of Delcath Systems, Inc. (DCTH) Phase III Clinical Trial for Inoperable Metastatic Melanoma 3/23/2009
More...
|
Adherex Technologies Inc. (ADH)'s Drug Could Make Melanoma More Vulnerable To Chemo, Duke University Study 3/9/2009
More...
|
Synta Pharmaceuticals (JOBS) Suspends Elesclomol SYMMETRYSM Trial in Metastatic Melanoma 2/27/2009
More...
|
TransMolecular, Inc. Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma 12/22/2008
More...
|
Alnylam Pharmaceuticals (ALNY) Forms Collaboration with University of California, San Francisco (UCSF) to Investigate Therapeutic Silencing of Key Gene Implicated in Uveal Melanoma 12/10/2008
More...
|
Single Cancer Cell 'Poses Danger', University of Michigan Study 12/4/2008
More...
|
Genta Incorporated (GNTA) Release: Tesetaxel, a Leading Oral Taxane in Clinical Development, Receives FDA Designation as an Orphan Drug for Treatment of Patients with Advanced Melanoma 12/4/2008
More...
|
Provectus Pharmaceuticals Inc. Release: Enrollment in Provectus’ Phase 2 Melanoma Clinical Trial Reaches Halfway Point 11/25/2008
More...
|
Thallion Pharmaceuticals Inc. Initiates Enrollment in Phase II Metastatic Melanoma Trial 11/18/2008
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Reaches Agreement With FDA on Special Protocol Assessment for Phase 3 Thymalfasin Trial in Stage IV Melanoma 11/17/2008
More...
|
CuraGen Corporation (CRGN) Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 11/3/2008
More...
|
Provectus Pharmaceuticals Inc. Adds Fifth Center to Phase 2 Clinical Trial of PV-10 10/31/2008
More...
|
T-Cell Infusion Therapy Boosts Melanoma Survival, French Researchers Say 10/23/2008
More...
|
Provectus Pharmaceuticals Inc. Announces First Peer-Reviewed Publication on PV-10 in "Melanoma Research" 10/14/2008
More...
|
Ludesi's 2D Gel Image Analysis Enabled Discovery of Potential Therapeutic Targets for Melanoma Tumors 10/14/2008
More...
|
Genta Incorporated (GNTA) Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma 10/6/2008
More...
|
Investigator Presents On Delcath Systems, Inc. (DCTH) Phase III Trial Experience 10/6/2008
More...
|
Provectus Pharmaceuticals Inc. Lead Investigator Professor John F. Thompson Presents At "Perspectives in Melanoma XII" Conference 10/2/2008
More...
|
Delcath Systems, Inc. (DCTH) Adds Providence Cancer Center to Phase III Trial 9/24/2008
More...
|
Variant Of Vitamin D Receptor Gene Linked To Melanoma Risk, University of Padova Study 9/22/2008
More...
|
Genta Incorporated (GNTA) Announces Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma 9/15/2008
More...
|
Bristol-Myers Squibb Company (BMY) and Medarex, Inc. (MEDX) Release: Updated Survival Data from Three Phase 2 Ipilimumab Studies Showed Almost Half of Previously Treated Metastatic Melanoma Patients Alive Beyond One Year 9/15/2008
More...
|
CuraGen Corporation (CRGN) Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma 9/11/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Include Swedish Medical Center in Colorado 8/21/2008
More...
|
Widely Prescribed Anti-parasite Drug Targets Cancer-causing Protein, New York University Cancer Institute and the Ronald O. Perelman Department of Dermatology Study 8/13/2008
More...
|
National Cancer Institute Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R) 8/12/2008
More...
|
GammaCan International, Inc. (GCAN.OB) Release: VitiGam(TM) Inhibits Melanoma Growth in a Dose Dependent Manner 8/11/2008
More...
|
Widely Prescribed Anti-parasite Drug Targets Cancer-causing Protein, New York University Cancer Institute and Ronald O. Perelman Department of Dermatology Research 8/7/2008
More...
|
Electro-Optical Sciences, Inc. Completes Patient Accrual in MelaFind(R) Pivotal Trial for Early Melanoma Detection 8/4/2008
More...
|
Protein Gives Doctors New Tool to Detect Melanoma in University of Rochester Study 7/24/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Florida 7/24/2008
More...
|
PhiloGene, Inc. Announces that VEGFbTM has been Granted Orphan Drug Designation by the FDA for the Treatment of Advanced Melanoma 7/22/2008
More...
|
Provectus Pharmaceuticals Inc. Adds M. D. Anderson Cancer Center as First U.S. Center to Phase 2 Clinical Trial of PV-10 7/21/2008
More...
|
Provectus Pharmaceuticals Inc.'s Lead Investigator for Phase 2 Melanoma Study to Address the Inaugural Sydney Cancer Conference 2008 7/17/2008
More...
|
Schering-Plough Corporation (SGP)'s (JOBS) Pegintron Cuts Melanoma Return Risk in Phase 3 Study 7/11/2008
More...
|
Provectus Pharmaceuticals Inc. Release: First Twenty-Five Percent of Subjects in Phase 2 Melanoma Clinical Trial Treated 7/7/2008
More...
|
Journal of Clinical Oncology Publishes Bayer HealthCare Pharmaceuticals (BAY)' Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 7/1/2008
More...
|
Hana Biosciences, Inc. (HNAB) Receives U.S. Orphan Drug Designation for Marqibo for the Treatment of Metastatic Uveal Melanoma 6/30/2008
More...
|
Painkillers Don't Protect Against Melanoma, Kaiser Permanente Northern California Research Finds 6/25/2008
More...
|
Genta Incorporated (GNTA) Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma Clinical Study on Track to Complete Accrual in Fourth Quarter 2008 6/24/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Multi-Center Phase III Trial for Metastatic Melanoma 6/24/2008
More...
|
University of Utah Melanoma Study: Genetic Test Determines Those at High-Risk for Deadly Cancer 6/23/2008
More...
|
Delcath Systems, Inc. (DCTH) Adds Atlantic Health to Phase III Trial for Metastatic Melanoma 6/19/2008
More...
|
Pain Therapeutics (PTIE) Encouraged by Results of Melanoma Clinical Study 6/16/2008
More...
|
Australia and New Zealand Melanoma Trials Group (ANZMTG) and Provectus Pharmaceuticals Inc. Release: Industry Supports International Research on New Melanoma Treatments 6/13/2008
More...
|
Novel Targeted Therapy Reduces Chemoresistance In Mouse Model Of Melanoma, University Medical Center Göttingen Study 6/11/2008
More...
|
CuraGen Corporation (CRGN) Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 6/11/2008
More...
|
Neoprobe Corporation (NEOP) Commences Lymphoseek Phase 3 Trial 6/9/2008
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Release: Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients - Phase II Data Indicate Overall and Disease-Free Survival 6/6/2008
More...
|
Delcath Systems, Inc. (DCTH) Adds the Cancer Center of Albany Medical Center to Phase III Trial for Metastatic Melanoma 6/4/2008
More...
|
GammaCan International, Inc. (GCAN.OB) Executes Supply Agreement with Bio Products Laboratory to Manufacture VitiGam(TM) for the Treatment of Melanoma for Clinical Testing and Commercial Sale 6/4/2008
More...
|
Medarex, Inc. (MEDX) Shares Fall Monday On Concerns Over Late-Stage Melanoma Drug Candidate Ipilimumab 6/3/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Hospital & Health Network Cancer Center 6/3/2008
More...
|
ANTISENSE PHARMA GmbH Release: Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 6/3/2008
More...
|
Abnormalities In Gene For Melanoma Found, Oregon Health & Science University (OHSU) Study 6/2/2008
More...
|
Hana Biosciences, Inc. (HNAB)' Phase 2 Clinical Trial of Marqibo for Metastatic Uveal Melanoma Meets Clinical Response Criteria to Advance to Full Enrollment 6/2/2008
More...
|
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 6/2/2008
More...
|
Medarex, Inc. (MEDX)'s Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma; Updated Clinical Phase 2 Data Presented at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
CuraGen Corporation (CRGN) Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity Of CR011-Vcmmae In Metastatic Melanoma - Data Presented At The 2008 American Society of Clinical Oncology Annual Meeting - - Conference Call To Be Hosted Wednesday, June 4 At 9:00 A.M. EDT To Discuss Results 6/2/2008
More...
|
Bristol-Myers Squibb Company (BMY), Medarex, Inc. (MEDX) Release: New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Adherex Technologies Inc. (ADH) Announces Updated ADH-1 Chemotherapy Combination Data in Melanoma 6/2/2008
More...
|
TransMolecular, Inc. Reports Positive Results from Phase 1 Trial of 131Iodine-TM601 in Metastatic Melanoma 6/2/2008
More...
|
Genta Incorporated (GNTA) Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma 5/30/2008
More...
|
TransMolecular, Inc. Initiates Phase 1 Clinical Trial for Unlabeled TM601 in Recurrent Malignant Glioma 5/30/2008
More...
|
GlaxoSmithKline (GSK) and Synta Pharmaceuticals Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 5/20/2008
More...
|
Skin-Tone Gene Could Predict Cancer Risk, Queensland Institute of Medical Research Study 5/19/2008
More...
|
Novel Enzyme Inhibitor Paves Way For New Cancer Drug: Agent Proves Effective Against Melanoma Cells, The Wistar Institute Study 5/19/2008
More...
|
Adherex Technologies Inc. (ADH) Announces American Society of Clinical Oncology Abstract of ADH-1 in Melanoma 5/19/2008
More...
|
Penn State University Scientists Identify Interacting Proteins Key To Melanoma Development, Treatment 5/6/2008
More...
|
Bristol-Myers Squibb Company (BMY), Medarex, Inc. (MEDX) Cancer Drug Hits Delay 4/28/2008
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center 4/28/2008
More...
|
Melanoma's Site May Determine Survival; Study Shows Neck, Scalp Melanoma Have Worst Survival Outcomes 4/22/2008
More...
|
BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma 4/22/2008
More...
|
First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Research 4/21/2008
More...
|
Report Describes First Targeted Therapy To Produce Remission Of Metastatic Melanoma, Dana-Farber Cancer Institute Study 4/18/2008
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 4/18/2008
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Data from Nonclinical Studies of SNS-032 4/16/2008
More...
|
Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 4/15/2008
More...
|
New Study Shows KGK Synergize's Dermytol Produces Pronounced Decrease In Malignant Melanoma Tumor Volume 4/7/2008
More...
|
Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma 4/2/2008
More...
|
DSMB Supports Continuation of Genta Incorporated (GNTA) Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3/31/2008
More...
|
Adherex Technologies Inc. (ADH) to Present ADH-1 Phase I/II Melanoma Trial Data at the 2008 Annual Meeting of the American Society of Clinical Oncology 3/20/2008
More...
|
Huntsman Cancer Institute Release: Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma 3/13/2008
More...
|
Inovio Biomedical Corporation's Electroporation Delivery Technology Demonstrates Safety and Positive Clinical Responses with Melanoma DNA Immunotherapy 3/11/2008
More...
|
EpiCept Corporation (EPCT) Earns Milestone Payment Due to Progress in Phase II Trial for Azixa(TM) in Melanoma Metastases 3/6/2008
More...
|
GammaCan International, Inc. (GCAN.OB) Announces Positive Testing Results in the Development of VitiGam(TM) for the Treatment of Melanoma 3/6/2008
More...
|
Ichor Medical Systems, Inc. Melanoma Vaccine Clinical Trial Moves to Highest Dose Level 3/4/2008
More...
|
Adherex Technologies Inc. (ADH) Receives Orphan Drug Designation for ADH-1 in Melanoma 2/22/2008
More...
|
Antisoma PLC (ASM.L) Starts Phase I Clinical Trial of AS1409 in Renal Cancer and Melanoma 2/21/2008
More...
|
Antigenics Inc. (New York) (AGEN) Cancer Vaccine Study Shows Mixed Results 2/20/2008
More...
|
Marshall Edwards, Inc. (NVGN)'s Triphendiol Gets Additional Orphan Drug Status 2/19/2008
More...
|
Researchers at The Cancer Center at Hackensack University Medical Center Participate in Study to Treat Advanced Melanoma 2/19/2008
More...
|
Howard Hughes Medical Institute Researchers Uncover Protein That Stops Melanoma Growth 2/8/2008
More...
|
Tysabri May Be Linked to Melanoma 2/7/2008
More...
|
Schering-Plough Corporation (SGP)'s Peg-IFN Gets FDA Priority Review Status 1/31/2008
More...
|
GlaxoSmithKline (GSK), Synta Pharmaceuticals Skin Cancer Drug Gets Orphan Status 1/28/2008
More...
|
Adherex Technologies Inc. (ADH) Announces Phase IIb Expansion of ADH-1 Combination Study in Melanoma 1/18/2008
More...
|
Vical Incorporated (VICL) Receives Payment from AnGes MG Inc. for Allovectin-7(R) Phase 3 Pivotal Trial 1/17/2008
More...
|
Electro-Optical Sciences, Inc. Announces MelaFind(R) Development Update 1/9/2008
More...
|
UIC Studies New Treatment for Advanced Melanoma 1/9/2008
More...
|
The Angeles Clinic and Research Institute Initiates Global Phase 3 Clinical Trial for New Melanoma Drug 1/7/2008
More...
|
AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma 1/3/2008
More...
|
IDM Pharma, Inc. (IDMI) Says Sanofi-Aventis (France) (SASY.PA) to End Venture, Sees Jobs Losses 12/31/2007
More...
|
University Hospitals Researchers Initiate Gene Therapy Trial in Patients with Advanced Skin Cancer 12/26/2007
More...
|
FDA Extends Review Period for Correction of Genasense Data- Genta Incorporated (GNTA) 12/21/2007
More...
|
Array BioPharma, Inc. (ARRY) Says AstraZeneca PLC (AZN) Not Taking AZD6244 to Phase III 12/20/2007
More...
|
DermTech International Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma 12/19/2007
More...
|
ZymoGenetics, Inc. (ZGEN) Begins Phase 2 Clinical Trial of IL-21 in Melanoma 12/18/2007
More...
|
ImClone Systems Incorporated (IMCL): Phase II Study of IMC-1121B for Advanced Malignant Melanoma Commences Patient Enrollment 12/13/2007
More...
|
Mixed Results from Bristol-Myers Squibb Company (BMY) (Jobs) and Medarex, Inc. (MEDX) Melanoma Trials 12/11/2007
More...
|
Specialists at Moores University of California, San Diego (UCSD) Cancer Center Evaluate New Option for Treating Advanced Melanoma 12/11/2007
More...
|
Bristol-Myers Squibb Company (BMY) and Medarex, Inc. (MEDX) Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 12/11/2007
More...
|
AVAX Technologies, Inc. (AVXT) Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 Melanoma 12/11/2007
More...
|
John Wayne Cancer Institute: Allovectin-7® May Offer Patients a New Option for Advanced Melanoma 12/5/2007
More...
|
University of Michigan: Cancer Drug Works by Overactivating Cancer Gene; Melanoma Tumors Carry Enemy Within, Suggesting New Treatment Strategy 11/26/2007
More...
|
Hana Biosciences, Inc. (HNAB) Initiates Marqibo Phase 2 Clinical Trial 11/21/2007
More...
|
Cancer Drug Works by Overactivating Cancer Gene, University of Michigan Health System Study 11/20/2007
More...
|
AVAX Technologies, Inc. (AVXT) Announces the Initiation of Its Phase III Registration Trial of M-Vax(R) in Metastatic Melanoma 11/13/2007
More...
|
Synta Pharmaceuticals Reaches Agreement on Special Protocol Assessment and Initiates SYMMETRY Trial - a Pivotal Phase 3 Clinical Trial of Elesclomol in Metastatic Melanoma 11/12/2007
More...
|
Genta Incorporated (GNTA) Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 11/8/2007
More...
|
IDM Pharma, Inc. (IDMI) Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 11/2/2007
More...
|
M. D. Anderson Cancer Center Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma 11/1/2007
More...
|
Society for Melanoma Research Genes Unlock New Treatments for Deadly Melanoma 10/26/2007
More...
|
CuraGen Corporation (CRGN) Announces Presentation of Phase I Dose-Escalation Results on CR011 10/25/2007
More...
|
Genta Incorporated (GNTA) Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress 10/24/2007
More...
|
Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma, University of Arkansas for Medical Sciences Study 10/17/2007
More...
|
Southeastern Medical Oncology Center: Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma 10/10/2007
More...
|
Drug Study Seeks Those with Advanced Skin Cancer 10/1/2007
More...
|
GammaCan International, Inc. (GCAN.OB) Enters into Vitiligo Plasma Supply Agreement with DCI Biologicals 10/1/2007
More...
|
New Type of Drug Shows Promise in Attacking Melanoma in An Innovative Way 9/26/2007
More...
|
Lucid Release: Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 9/18/2007
More...
|
Oncolytics Biotech Inc. (ONC.TO) Release: Reovirus Infection of Melanoma Cells Generates Anti-Tumour Immunity 9/12/2007
More...
|
St. Luke's Hospital & Health Network: Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma 9/10/2007
More...
|
Neoprobe Corporation (NEOP) Provides Updated Phase 2 Clinical Data for Lymphoseek® 9/10/2007
More...
|
Melanoma Drug Revs Immune Cells But Cancer Cells Ignore It, Ohio State University Study 9/6/2007
More...
|
Genta Incorporated (GNTA) Release: Genasense(R) Data in Melanoma to be Presented 9/5/2007
More...
|
Provectus Pharmaceuticals Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma 9/5/2007
More...
|
Cyplasin Biomedical Ltd. (CYPL.OB) Release: Cyplasin-SC(TM) Kills Melanoma Cells, Even Derived from Different Patients but Leaves Normal Human Cells Unharmed 9/5/2007
More...
|
Advanced Life Sciences Holdings, Inc. (ADLS) Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma 8/28/2007
More...
|
Capitol Comprehensive Cancer Care Clinic: Allovectin-7® May Offer Patients a New Option for Advanced Melanoma 8/27/2007
More...
|
Genta Incorporated (GNTA) Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 8/21/2007
More...
|
Comprehensive Blood and Cancer Center: Allovectin-7® May Offer Patients a New Option for Advanced Melanoma 8/20/2007
More...
|
GammaCan International, Inc. (GCAN.OB) Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma 8/7/2007
More...
|
European Medicines Evaluation Agency Indicates that Genta Incorporated (GNTA)'s Genasense(R) Approval in Melanoma Will Require Confirmatory Clinical Trial 7/20/2007
More...
|
Moles 'Good Indicator to Ageing', 'Skin Cancer Risk' 7/12/2007
More...
|
Delcath Systems, Inc. (DCTH) Expands Phase II Multi-Histology Clinical Trial 6/26/2007
More...
|
Neoprobe Corporation (NEOP) Phase 2 Lymphoseek Trial Meets Primary Endpoint 6/20/2007
More...
|
New Blood Test Detects Likelihood of Melanoma 6/14/2007
More...
|
IDM Pharma, Inc. (IDMI) Presents Preliminary Results from Phase II UVIDEM(R) Melanoma Vaccine Clinical Trial 6/5/2007
More...
|
Medarex, Inc. (MEDX) and Bristol-Myers Squibb Company (BMY) Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab 6/5/2007
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) and Sigma-Tau Pharmaceuticals Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial 6/4/2007
More...
|
KOSAN Biosciences, Inc. (KOSN) Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at American Society of Clinical Oncology 6/4/2007
More...
|
Hana Biosciences, Inc. (HNAB) Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting 6/4/2007
More...
|
SciClone Pharmaceuticals, Inc. (SCLN)'s SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study 6/4/2007
More...
|
Inovio Biomedical Corporation (INO)'s DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results 5/24/2007
More...
|
Synta Pharmaceuticals Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the American Society of Clinical Oncology Annual Meeting 5/23/2007
More...
|
Nanocomposite Labeled Cancer Cells Can be Targeted and Destroyed Using Lasers, Roswell Park Cancer Institute and University of Michigan Study 5/21/2007
More...
|
Morphotek Inc. Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma 5/21/2007
More...
|
Provectus Pharmaceuticals Inc. Releases Video of Provecta(TM) in Action on Human Patient 5/21/2007
More...
|
U.S. National Cancer Institute Files for Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R) 5/14/2007
More...
|
FDA Approves Phase I Clinical Trial Using Ichor Medical Systems, Inc.'s TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering 5/14/2007
More...
|
Uveal Melanoma Patients at Higher Risk for Colon Cancer 5/9/2007
More...
|
Stanford University School of Medicine(Jobs) Researchers Identify Immune Dysfunction in Melanoma Patients 5/8/2007
More...
|
Viragen, Inc. (VRA) Multiferon(R) Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published 5/8/2007
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Announces ZADAXIN and SCV-07 Abstracts Accepted at American Society of Clinical Oncology 4/27/2007
More...
|